Planegg/Martinsried, March 4, 2024. Medigene AG (Medigene, FSE: MDG1, Prime Standard), an immuno-oncology platform company focusing on the discovery and development of T cell immunotherapies for solid ...
Danbury, Connecticut/Perrysburg, Ohio, March 24, 2025 (GLOBE NEWSWIRE) -- O-I Glass, Inc. (OI) (“O-I Glass” or “O-I”) and Linde today announced plans to ...
Planegg/Martinsried, April 4, 2024. Medigene AG (Medigene, FSE: MDG1, Prime Standard), an immuno-oncology platform company focusing on the discovery and development of T cell immunotherapies for solid ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results